ArticleJournal of pediatrics. Clinical practice2026
Early-Onset Sepsis in Preterm Neonates of 22-28 Weeks' Gestation: An International Cohort Study.
Article in Journal of pediatrics. Clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Early-onset sepsis (EOS) is associated with increased mortality and morbidity in preterm neonates. We aim to study the epidemiology of EOS among extremely preterm neonates across a multinational neonatal registry. Study design: A retrospective cohort study (2007-2023) of neonates born under 28 weeks' gestation from the International Network for Evaluation of Outcomes in Neonates collaboration, involving 11 national neonatal registries. The definition of EOS was blood or cerebrospinal fluid culture-positive sepsis within the first days after birth (ranging from <2 to <7 days of life). Primary outcome was mortality. Secondary outcome was major morbidities (severe neurological injury, severe retinopathy of prematurity, necrotizing enterocolitis, late-onset sepsis, or bronchopulmonary dysplasia). Univariate and multivariate analyses were performed. Results: Four thousand three hundred fifty-four of 130,938 (3.3%) neonates with mean (±SD) gestational age 26.1 (±1.7) weeks and birthweight 874 (±241) grams developed EOS. Rates of EOS ranged from 1.6% to 6.6% across International Network for Evaluation of Outcomes in Neonates countries. Pregnancy associated hypertension and caesarean delivery were not associated with EOS. For EOS infants the mortality rate was 35.5% and mortality or morbidity rate was 78.2%. Odds of mortality remained higher after adjustment (AOR, 2.49; 95% CI: 2.27, 2.74) along with mortality or morbidity (AOR, 1.89; 95% CI, 1.70-2.10). Severe neurological injury was the leading complications (AOR, 2.34; 95% CI, 2.11-2.59). Variations in incidence, morbidity, and mortality were also noted between countries. Conclusion: EOS is common in extremely preterm neonates, varying across countries and associated with higher odds of mortality and morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.